We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
+31.44%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$719M
AUM Growth
-$27.1M
(-3.6%)
Cap. Flow
-$214M
Cap. Flow
% of AUM
-29.71%
Top 10 Holdings %
Top 10 Hldgs %
66.29%
Holding
201
New
72
Increased
18
Reduced
27
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Travelers Companies
TRV
|
+$7.93M |
| 2 |
FNB Corp
FNB
|
+$7.61M |
| 3 |
Sherwin-Williams
SHW
|
+$7.06M |
| 4 |
Allstate
ALL
|
+$5.58M |
| 5 |
Willis Towers Watson
WTW
|
+$5.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$274M |
| 2 |
Celanese
CE
|
+$6.41M |
| 3 |
MON
Monsanto Co
MON
|
+$6.27M |
| 4 |
Bunge Global
BG
|
+$5.97M |
| 5 |
Air Products & Chemicals
APD
|
+$4.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.98% |
| 2 | Industrials | 5.93% |
| 3 | Healthcare | 5.67% |
| 4 | Technology | 4.78% |
| 5 | Communication Services | 1.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELLI
51
DELISTED
Ellie Mae Inc
ELLI
| $2.51M | 0.35% |
+30,530
| New | +$2.8M |
|
52
Match Group
MTCH
$9.19B
| $2.43M | 0.34% |
+104,750
| New | +$2.11M |
|
|
FDC
53
DELISTED
First Data Corporation
FDC
| $2.43M | 0.34% |
+134,460
| New | +$2.45M |
|
|
WAGE
54
DELISTED
WageWorks, Inc.
WAGE
| $2.37M | 0.33% |
+39,106
| New | +$2.38M |
|
|
TVPT
55
DELISTED
Travelport Worldwide Limited
TVPT
| $2.31M | 0.32% |
+147,141
| New | +$2.15M |
|
56
PayPal
PYPL
$48.9B
| $2.3M | 0.32% |
+35,980
| New | +$2.16M |
|
57
American Financial Group
AFG
$11.8B
| $2.25M | 0.31% |
21,785
+10,788
| +98% | +$1.1M |
|
58
Euronet Worldwide
EEFT
$2.72B
| $2.24M | 0.31% |
+23,661
| New | +$2.24M |
|
59
Salesforce
CRM
$151B
| $2.24M | 0.31% |
+23,984
| New | +$2.21M |
|
60
Raymond James Financial
RJF
$33.8B
| $2.22M | 0.31% |
+39,459
| New | +$2.13M |
|
61
Box
BOX
$4.37B
| $2.15M | 0.3% |
+111,101
| New | +$2.09M |
|
|
FPRX
62
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2.08M | 0.29% |
+50,919
| New | +$1.6M |
|
63
Insmed
INSM
$21.4B
| $2.04M | 0.28% |
+65,419
| New | +$1.25M |
|
|
FIT
64
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $2.03M | 0.28% |
+291,529
| New | +$1.7M |
|
|
KDMN
65
DELISTED
Kadmon Holdings, Inc.
KDMN
| $2.01M | 0.28% |
+600,228
| New | +$1.71M |
|
66
Bank of Hawaii
BOH
$3.15B
| $2M | 0.28% |
24,000
| – | – |
|
67
Assurant
AIZ
$13.8B
| $1.95M | 0.27% |
20,359
-4,017
| -16% | -$401K |
|
|
ATH
68
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $1.95M | 0.27% |
36,130
-4,568
| -11% | -$236K |
|
69
W.R. Berkley
WRB
$26.9B
| $1.94M | 0.27% |
98,145
+21,657
| +28% | +$434K |
|
70
Agios Pharmaceuticals
AGIO
$1.79B
| $1.94M | 0.27% |
+29,025
| New | +$1.74M |
|
|
RETA
71
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.88M | 0.26% |
+60,464
| New | +$1.82M |
|
|
EV
72
DELISTED
Eaton Vance Corp.
EV
| $1.82M | 0.25% |
+36,861
| New | +$1.76M |
|
|
INFO
73
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $1.8M | 0.25% |
+40,768
| New | +$1.88M |
|
|
FITB
74
Fifth Third Bancorp
FITB
$51.2B
| $1.79M | 0.25% |
64,000
-21,000
| -25% | -$557K |
|
75
Reinsurance Group of America
RGA
$15.5B
| $1.78M | 0.25% |
12,743
-14,286
| -53% | -$1.93M |
|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q3 2017 Portfolio in Review
As of Q3 2017, Crestline Management held 201 positions worth $719M, down 3.6% from $746M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Crestline Management withdrew a net $214M in Q3 2017, closing 81 positions and reducing 27 holdings. Its most notable exit was Celanese, an estimated $6.41M position sold in full.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 13% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Crestline Management opened a new position in Travelers Companies worth $7.78M.
- Crestline Management's largest Q3 2017 buy was Travelers Companies: 63,503 shares worth $7.78M.
- Crestline Management added most to FNB Corp in Q3 2017, an estimated $7.61M increase.
- Crestline Management's biggest Q3 2017 reduction was Juno Therapeutics, Inc., cutting an estimated $274M.
- Crestline Management fully exited Celanese in Q3 2017, selling an estimated $6.41M.
- Crestline Management's ten largest holdings make up 66% of its $719M portfolio in Q3 2017.
- Crestline Management opened 72 new positions and closed 81 in Q3 2017.
- Crestline Management's portfolio value fell 3.6% quarter-over-quarter to $719M.
Based on Crestline Management's 13F filing for Q3 2017, filed 14 Nov 2017.